Retatrutide Prefilled Pen
The Retatrutide Prefilled Pen contains Retatrutide, a synthetic peptide described in research as a triple agonist (GLP-1, GIP and glucagon), in a prefilled dosing pen for accurate volume delivery in research setups.
Research context
Retatrutide is studied in relation to the simultaneous activation of three receptor pathways in energy and glucose metabolism. The prefilled pen supports consistent dosing in comparative research. Intended for research use only.
Specifications
- Compound: Retatrutide
- Form: prefilled dosing pen
- Available dosages: 20 mg, 30 mg, 50 mg, 60 mg
- Purity: >99% (HPLC verified)
Storage
Store refrigerated according to the provided instructions.
Disclaimer
For laboratory and research use only. Not for human or animal consumption, and not for diagnostic or therapeutic use.
Certificate of Analysis
Independently tested by Janoshik. Sample RT20 · Batch 2026-06 · Retatrutide 21.80 mg · Purity 99.721% (HPLC). Analysis date 23 Jun 2026.
Download the Certificate of Analysis (PDF) — verify at janoshik.com/verify with key MP9UX7XUZWKR.
